Beta Bionics, Inc. Common Stock (BBNX) — Long-term Investment Intensity
Beta Bionics, Inc. Common Stock (BBNX) has a Long-term Investment Intensity of 13.1% as of March 2026. Long-term investments of $39.87 Million represent 13.1% of total assets of $304.42 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Explore BBNX cash flow metrics to assess how effectively this company generates cash.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Beta Bionics, Inc. Common Stock Long-term Investment Intensity (2025–2025)
This chart shows how Beta Bionics, Inc. Common Stock's Long-term Investment Intensity has evolved across 1 annual periods from 2025 to 2025. As of March 2026, the intensity stands at 13.1%, reflecting long-term investments of $39.87 Million against total assets of $304.42 Million USD. Explore Beta Bionics, Inc. Common Stock cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Beta Bionics, Inc. Common Stock (2025–2025)
The table below presents the year-by-year Long-term Investment Intensity for Beta Bionics, Inc. Common Stock from 2025 to 2025, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see market cap of Beta Bionics, Inc. Common Stock.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 13.8% | $45.43 Million | $328.74 Million | — |